Harvard Business Review

JANUARY 31, 2013

McKinsey has identified more than 20 distinct submarkets in China, for example. Pharmaceutical companies are mastering bio-engineering techniques that will help develop personalized medicines. Innovations Are Changing The Way We Design Products. On the innovation front, the opportunities are more diverse, but equally powerful.

Globalization 9

Globalization Supply Chain Pharmaceuticals McKinsey 9

Harvard Business Review

JANUARY 23, 2015

A way around this fallacy, we’ve found, is a speed-dating version of scenario planning, one that takes hours rather than months. For example, the group defined the education driver as “the degree to which US elementary through higher education has developed curricula to produce science and technical talent.”

Kahneman 8

Kahneman Scenario Planning Pharmaceuticals Workshop 8

Harvard Business Review

JUNE 20, 2017

For example, a key source of concern for some companies is more-restrictive rules of origin, which would reduce the amount of materials allowed to be used tariff-free for products traded to and from NAFTA member countries. Multinationals are heavily pushing for either minor tweaking to the agreement or a modernization of NAFTA.

Supply Chain 8

Supply Chain Depreciation Uncertainty Marketing 8